Dr Andrew Young

Research Fellow

Chappell Group

Dr Andrew Young is a Research Fellow currently working on the development of subunit vaccines for common respiratory viral diseases. He completed his PhD at the University of Queensland in 2019 and has since been developing vaccines for Respiratory Syncytial Virus and human Metapneuovirus. His PhD project focussed primarily on Ebola Virus, specifically the development of subunit vaccine candidates and diagnostics using the EBOV surface fusion glycoprotein.

Qualifications

Bsc. Hons 1st class

PhD

Publications

Young A, Isaacs A, Scott CAP, Modhiran N, McMillan CLD, Cheung STM, Barr J, Marsh G, Thakur N, Bailey D, Li KSM, Luk HKH, Kok KH, Lau SKP, Woo PCY, Furuyama W, Marzi A, Young PR, Chappell KJ, Watterson D. A platform technology for generating subunit vaccines against diverse viral pathogens. Front Immunol. 2022 Aug 18;13:963023. doi: 10.3389/fimmu.2022.963023. PMID: 36059532; PMCID: PMC9436389.

Watterson, D., Wijesundara, D.K., Naphak Modhiran, Mordant, F.L., Li, Z., Michael Selorm Avumegah, Christopher, Lackenby, J., Guilfoyle, K., Geert van Amerongen, Stittelaar, K.J., Stacey, Bibby, S., Daleris, M., Hoger, K., Gillard, M., Radunz, E., Jones, M.L., Hughes, K., Hughes, B., ... (2021). Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2. Clinical & translational immunology, 10(4). doi:https://doi.org/10.1002/cti2.1269.

Isaacs, A., Cheung, S.T.M., Thakur, N., Jaberolansar, N., Young, A., Modhiran, N., Bailey, D., Graham, S.P., Young, P.R., Chappell, K.J. and Watterson, D. (2021). Combinatorial F-G Immunogens as Nipah and Respiratory Syncytial Virus Vaccine Candidates. Viruses, [online] 13(10), p.1942. doi:https://doi.org/10.3390/v13101942.

Featured projects	Duration
ViceBio	2019–2024